PS==As more people catch on to RIBT being partly a

PS==As more people catch on to RIBT being partly a nutraceutica;l/pharm company the stock will soar.

They have in the wings a pain product called BiFlexin.  It needs money for human testing. And testing could take a couple of years.  I know a fellow RIBT shareholder who used to live near the Phoenix headquarters and knew the former and present CEO.  This is hearsay, but he claims it is just as strong as Vioxx, but all natural and won't kill people like Vioxx did.  I look for a nutraceutical deal before the end of the year that might give RIBT money for testing.

http://www.yourlawyer.com/topics/overview/vioxx